Benign Prostate Hyperplasia Clinical Trial
Verified date | January 2017 |
Source | Yonsei University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to evaluate the change of the hemodynamic profiles on bio reactance technique during TURP in elderly patients.
Status | Completed |
Enrollment | 20 |
Est. completion date | February 27, 2016 |
Est. primary completion date | February 27, 2016 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 65 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1) Twenty (ASA status I ~ III) patients, ages 65 to 80 yr old, who were scheduled for transurethral resection of the prostate under spinal anesthesia Exclusion Criteria: 1. if there were contraindications for spinal anesthesia including hypersensitivity to any local anaesthetics, bleeding diathesis, infections at the puncture sites, or pre-existing neurological disease. 2. history of coronary artery bypass surgery 3. history of dementia 4. have a difficulty in understanding informed consent or refuse to sign the informed consent 5. patients height under 150 cm |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Yonsei University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change of the hemodynamic profiles including cardiac index on NICOM during the TURP in elderly patients | (Cardiac output, stroke volume, Stroke volume index, Total peripheral resistance, heart rate, blood pressure) | change from baseline 1 min before the anesthesia, 10 min after anesthesia, 10 min after surgery, 20 min after surgery, 30 min after surgery, at the end of the surgery | |
Secondary | change of the electrolyte | from expected up to 3 months before surgery for preoperative evaluation to expected up to 3 hours after the end of surgery | ||
Secondary | change of the hemoglobin | from expected up to 3 months before surgery for preoperative evaluation to expected up to 3 hours after the end of surgery | ||
Secondary | estimated absorbed irrigation fluid during the surgery | Fluid absorbed = % decrease in sodium x ECF (0.2 x body weight) | during the surgery | |
Secondary | incidence of TURP syndrome | followed for the duration of hospital stay, an expected average of 7 days. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01942551 -
Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
|
Phase 1 | |
Completed |
NCT01436877 -
Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia
|
N/A | |
Completed |
NCT02822924 -
Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02390882 -
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
|
Phase 3 | |
Completed |
NCT02839122 -
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
|
Phase 1 | |
Not yet recruiting |
NCT01861041 -
Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.
|
Phase 4 | |
Completed |
NCT02332538 -
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH
|
N/A | |
Completed |
NCT01835860 -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
|
Phase 2/Phase 3 | |
Completed |
NCT01665586 -
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
|
N/A | |
Completed |
NCT02038868 -
A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
|
Phase 2 | |
Completed |
NCT02506465 -
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
|
N/A | |
Completed |
NCT01675895 -
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration
|
Phase 4 | |
Recruiting |
NCT02827578 -
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
|
Phase 3 | |
Completed |
NCT02352311 -
Safety and Pharmacokinetic Characteristics of DKF-313
|
Phase 1 | |
Completed |
NCT01494337 -
Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)
|
Phase 4 | |
Completed |
NCT01627522 -
Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate
|
Phase 2/Phase 3 | |
Completed |
NCT01952912 -
Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates
|
N/A | |
Active, not recruiting |
NCT01736033 -
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
|
Phase 4 | |
Recruiting |
NCT02021032 -
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
|
Phase 4 | |
Completed |
NCT00861588 -
Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia
|
N/A |